Treatment of Newly Diagnosed Glioblastoma Multiforme with Carmustine, Cisplatin and Etoposide Followed by Radiotherapy. A Phase II Study
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 43 (2) , 161-166
- https://doi.org/10.1023/a:1006254716877
Abstract
A meta-analysis and several studies of patients with grade III and IV gliomas have indicated that the addition of nitrosurea based chemotherapy to surgery and radiation may improve survival. We...Keywords
This publication has 15 references indexed in Scilit:
- Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.Journal of Clinical Oncology, 1997
- Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II studyEuropean Journal Of Cancer, 1996
- Tumoral platinum concentrations in patients treated with repeated low‐dose cisplatin as a radiosensitizerInternational Journal of Cancer, 1996
- Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant gliomaJournal of Neuro-Oncology, 1996
- Pre-radiation Chemotherapy for Malignant Glioma in AdultsCanadian Journal of Neurological Sciences, 1996
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI Journal of the National Cancer Institute, 1993
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990
- The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980